Funding
Series A · Healthtech

Bird & Be raises US$13m Series A for reproductive health products

BFG Partners and BDC Capital’s Thrive Venture Fund co-led the round.

Updated Oct 18, 2026By RoundOS Funding desk

Bird & Be has raised US$13 million in Series A financing co-led by BFG Partners and BDC Capital’s Thrive Venture Fund. BAM Ventures, Founder Collective, Rejuvenation Ventures and HSR Ventures also participated.

The Canadian company sells fertility supplements and at-home reproductive health tests. It will use the capital for product development and a wider retail presence.

Use of funds

Product development

Expand retail distribution

Funding history

Series A · This round$13M

Sources

  1. Financing announcementosler.com · Sep 22, 2026

Similar rounds

All Healthtech rounds →
Guoke Brain-Computer

Beijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.

UndisclosedSeed · Oct 23, 2026
SEGNOS

SEGNOS develops magnetic-particle materials and diagnostic technologies for blood testing.

UndisclosedPre-Series A · Oct 22, 2026
CureBay

CureBay operates a hybrid healthcare network for rural and underserved communities in India.

~₹1BPre-Series C · Oct 22, 2026
iCUREX

Kagoshima medical-device company developing chitosan hydrogel materials for wound care, including the syringe-delivered Kitosla CX dressing.

¥140MSeries A first close: equity and debt · Oct 22, 2026

Related